$38.19
4.26% yesterday
Nasdaq, Nov 15, 10:14 pm CET
ISIN
US52490G1022
Symbol
LEGN
Sector
Industry

Legend Biotech Corp - ADR Target price 2024 - Analyst rating & recommendation

Legend Biotech Corp - ADR Classifications & Recommendation:

Buy
92%
Hold
8%

Legend Biotech Corp - ADR Price Target

Target Price $81.80
Price $38.19
Potential
Number of Estimates 22
22 Analysts have issued a price target Legend Biotech Corp - ADR 2025 . The average Legend Biotech Corp - ADR target price is $81.80. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 26 analysts: 24 Analysts recommend Legend Biotech Corp - ADR to buy, 2 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Legend Biotech Corp - ADR stock has an average upside potential 2025 of . Most analysts recommend the Legend Biotech Corp - ADR stock at Purchase.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Million $ 285.14 619.87
143.69% 117.39%
EBITDA Margin -147.92% -42.76%
60.63% 71.09%
Net Margin -189.15% -26.36%
57.07% 86.06%

23 Analysts have issued a sales forecast Legend Biotech Corp - ADR 2024 . The average Legend Biotech Corp - ADR sales estimate is

$620m
Unlock
. This is
19.16% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$736m 41.56%
Unlock
, the lowest is
$562m 8.04%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $285m 143.69%
2024
$620m 117.39%
Unlock
2025
$1.0b 68.83%
Unlock
2026
$1.5b 47.89%
Unlock
2027
$2.1b 36.90%
Unlock
2028
$2.6b 23.00%
Unlock

10 Analysts have issued an Legend Biotech Corp - ADR EBITDA forecast 2024. The average Legend Biotech Corp - ADR EBITDA estimate is

$-265m
Unlock
. This is
19.51% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$-165m 49.88%
Unlock
, the lowest is
$-374m 13.56%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 $-422m 4.07%
2024
$-265m 37.15%
Unlock
2025
$-101m 62.06%
Unlock
2026
$177m 275.54%
Unlock
2027
$397m 125.04%
Unlock
2028
$642m 61.58%
Unlock

EBITDA Margin

2023 -147.92% 60.63%
2024
-42.76% 71.09%
Unlock
2025
-9.61% 77.53%
Unlock
2026
11.41% 218.73%
Unlock
2027
18.75% 64.33%
Unlock
2028
24.63% 31.36%
Unlock

12 Legend Biotech Corp - ADR Analysts have issued a net profit forecast 2024. The average Legend Biotech Corp - ADR net profit estimate is

$-163m
Unlock
. This is
53.36% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-95.4m 72.78%
Unlock
, the lowest is
$-314m 10.31%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $-539m 4.63%
2024
$-163m 69.70%
Unlock
2025
$-69.7m 57.34%
Unlock
2026
$116m 266.50%
Unlock
2027
$251m 116.58%
Unlock
2028
$425m 68.94%
Unlock

Net Margin

2023 -189.15% 57.07%
2024
-26.36% 86.06%
Unlock
2025
-6.66% 74.73%
Unlock
2026
7.50% 212.61%
Unlock
2027
11.86% 58.13%
Unlock
2028
16.30% 37.44%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share $ -2.94 -0.89
4.63% 69.73%
P/E negative
EV/Sales 9.90

12 Analysts have issued a Legend Biotech Corp - ADR forecast for earnings per share. The average Legend Biotech Corp - ADR <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$-0.89
Unlock
. This is
53.40% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$-0.52 72.77%
Unlock
, the lowest is
$-1.71 10.47%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $-2.94 4.63%
2024
$-0.89 69.73%
Unlock
2025
$-0.38 57.30%
Unlock
2026
$0.63 265.79%
Unlock
2027
$1.37 117.46%
Unlock
2028
$2.31 68.61%
Unlock

P/E ratio

Current -20.02 9.12%
2024
-42.87 114.14%
Unlock
2025
-100.51 134.45%
Unlock
2026
60.36 160.05%
Unlock
2027
27.87 53.83%
Unlock
2028
16.50 40.80%
Unlock

Based on analysts' sales estimates for 2024, the Legend Biotech Corp - ADR stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of
11.30
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 11.80 85.26%
2024
9.90 16.06%
Unlock
2025
5.87 40.77%
Unlock
2026
3.97 32.38%
Unlock
2027
2.90 26.95%
Unlock
2028
2.36 18.70%
Unlock

P/S ratio

Current 13.47 85.07%
2024
11.30 16.08%
Unlock
2025
6.69 40.77%
Unlock
2026
4.53 32.38%
Unlock
2027
3.31 26.95%
Unlock
2028
2.69 18.70%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today